查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球细胞分析市场：按产品/服务（消耗品、仪器）、方法（流式细胞术、PCR、显微镜）、过程（计数、生存、增殖、相互作用、单细胞分析）和最终用户（製药、生物技术）预测到 2028 年
市场调查报告书
商品编码
1307909

全球细胞分析市场：按产品/服务（消耗品、仪器）、方法（流式细胞术、PCR、显微镜）、过程（计数、生存、增殖、相互作用、单细胞分析）和最终用户（製药、生物技术）预测到 2028 年

Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 242 Pages | 订单完成后即时交付

价格
简介目录

全球细胞分析市场规模预计在预测期内将以 10.9% 的复合年增长率增长，从 2023 年的 202 亿美元增至 2028 年的 339 亿美元。

各种癌症研究应用中越来越多地采用新型细胞检测方法，这是细胞分析市场的主要机遇之一。 另一方面，细胞分析仪价格昂贵，实验中使用的试剂有限，预计将抑制市场增长。

“分析期间（2021-2028）试剂和耗材领域将主导细胞分析市场”

通过按产品和服务划分的全球细胞分析市场来看，试剂和耗材领域在 2022 年占据了最大的市场份额。 经济实惠的耗材和试剂解决方案的便捷供应预计将推动基于细胞的研究活动，进一步促进市场增长。 在基于流式细胞术的细胞分析中使用专有试剂和消耗品预计将进一步推动该领域的增长。

“高内涵筛选 (HCS) 细分市场将在 2023 年至 2028 年间实现最高增长率”

高内涵筛选 (HCS) 技术将分析方法与高通量自动成像相结合，有助于提取多参数单细胞数据。 此外，HCS 在药物发现应用中的不断扩大应用预计将有助于该领域的强劲增长。

“2022年北美将获得细胞分析市场最高收入”

从按地区划分的全球细胞分析市场来看，北美将在 2022 年占据最大份额。 美国是该地区主要的收入贡献者，展示了强大的主要参与者网络，导致该地区的市场成熟。 此外，政府在鼓励学术和研究活动方面的积极作用正在为该地区创造有利可图的机会，并加剧北美细胞分析市场的竞争。

内容

第一章简介

第 2 章研究方法

第 3 章执行摘要

第 4 章重要考虑因素

第五章市场概述

  • 简介
  • 市场动态
    • 驱动程序
    • 制约因素
    • 机会
    • 任务
  • 波特五力分析
  • 价值链分析
  • 生态系统分析
  • 监管分析（基于流式细胞术的细胞分析）
  • 技术分析
  • 影响客户业务的趋势/干扰
  • 主要利益相关者和采购标准
  • 重大会议和活动（2023-2024）
  • 价格分析

第 6 章细胞分析市场：按产品/服务

  • 简介
  • 试剂和消耗品
  • 设备
  • 配件
  • 软件
  • 服务

第 7 章细胞分析市场：按技术

  • 简介
  • 流式细胞术
  • PCR
  • 细胞微阵列
  • 显微镜
  • 分光光度计
  • 高内涵筛选 (HCS)
  • 其他技术

第 8 章细胞分析市场：按流程

  • 简介
  • 细胞识别
  • 细胞存活
  • 细胞信号通路/信号转导
  • 细胞增殖
  • 细胞计数和质量控制
  • 细胞相互作用
  • 细胞结构研究
  • 目标识别和验证
  • 单细胞分析

第 9 章细胞分析市场：按最终用户划分

  • 简介
  • 製药和生物技术公司
  • 医院和临床实验室
  • 学术研究所
  • 其他最终用户

第 10 章细胞分析市场：按地区

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 亚太地区其他地区
  • 拉丁美洲
  • 中东和非洲

第 11 章竞争格局

  • 简介
  • 大公司采用的赢者获胜的方法
  • 市场份额分析
  • 收入份额分析：前 7 名公司
  • 公司评估象限
  • 竞争领导力地图：初创企业/中小企业/初创企业 (2022)
  • 竞争场景和趋势

第12章公司简介

  • 主要公司
    • THERMO FISHER SCIENTIFIC INC.
    • DANAHER
    • BECTON, DICKINSON AND COMPANY (BD)
    • GENERAL ELECTRIC
    • MERCK KGAA
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • STANDARD BIOTOOLS
    • MILTENYI BIOTEC
    • OLYMPUS CORPORATION
    • BIOSTATUS LIMITED
    • NANOCELLECT BIOMEDICAL
    • CELL BIOLABS, INC.
    • CREATIVE BIOARRAY
    • MEIJI TECHNO
  • 其他企业
    • PROMEGA CORPORATION
    • PERKINELMER U.S. LLC
    • TECAN TRADING AG
    • CARL ZEISS AG
    • SYSMEX
    • CELLINK
    • QIAGEN
    • ILLUMINA, INC.
    • CORNING INCORPORATED
    • 10X GENOMICS

第13章 附录

简介目录
Product Code: BT 2358

The global cell analysis market is projected to reach USD 33.9 Billion by 2028 from USD 20.2 Billion in 2023, at a CAGR of 10.9% during the forecast period. Increasing adoption of novel cellular assays in various cancer research applications is one of the key opportunities in the cell analysis market. On the other hand, expensive nature of cell analysis instruments coupled with limitations on usage of certain reagents for experiments is expected to restrain the market growth.

"The reagents & consumables segment dominates the cell analysis market through the study period of 2021-2028."

Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment represented largest market share for the year 2022, in cell analysis market. Availability of affordable consumables and reagent solutions is expected to drive the cell-based research activtites, further strengthening the market growth. Use of unique reagents & consumables in flow cytometry-based cell analysis is expected to further propel the segment growth.

"The high content screening (HCS) segment is set to register the highest growth in the cell analysis market from 2023-2028."

Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening (HCS), and other techniques. HCS The high content screening technique is a combination of analytical approaches and high-throughput automated imaging that aids in extraction of single-cell data which is multi-parametric in nature. Moreover, expanding applications of HCS in drug discovery applications are expected to contribute to the robust growth of this segment.

"North America generated highest revenue in cell analysis market in 2022."

Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2022, North America accounted for the largest share of the cell analysis market. US being the key revenue contributor to this region, exhibits a strong network of prominent industry players leading to market maturity in this region. Further, active role of the government to encourage academic & research activities create lucrative opportunities in this region, intensifying competition in the North America cell analysis market.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 37%, Tier 2: 23%, and Tier 3: 40%
  • By Designation - C-level: 32%, D-level: 26%, and Others: 42%
  • By Region - North America: 35%, Europe: 25%, Asia Pacific: 20%, Latin America: 12%, and the Middle East and Africa: 8%

List of Companies Profiled in the Report

  • Danaher (US)
  • Thermo Fisher Scientific (US)
  • Becton Dickinson and Company (US)
  • General Electric (US)
  • Merck KGaA (US)
  • Agilent Technologies (US)
  • Olympus Corporation (Japan)
  • Miltenyi Biotec (US)
  • Bio-Rad Laboratories (US)
  • BioStatus Limited (UK)
  • Fluidigm Corporation (US)
  • NanoCellect Biomedical (US)
  • Cell Biolabs (US)
  • Creative Bioarray (US)
  • Meiji Techno (US)
  • Promega Corporation (US)
  • PerkinElmer (US)
  • Tecan Trading AG (Switzerland)
  • CELLINK (US)
  • QIAGEN (Germany)
  • Corning Incorporated (US)
  • 10x Genomics (US)
  • Illumina (US)

Research Coverage:

This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technique, process, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell analysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the cell analysis market. The report analyses the cell analysis market by product & service, technique, process, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell analysis across key geographic regions.
  • Analysis of key drivers (rising preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growing number of drug discovery activities), restraints (high cost of instruments and restrictions on reagent use), and opportunities (high growth potential of single-cell sequencing, growing applications of cell-based assays in chronic diseases and personalized medicine).
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the cell analysis market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE)
    • FIGURE 4 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE SHARE ANALYSIS, 2022
    • FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2022)
  • 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • FIGURE 6 CELL ANALYSIS MARKET: CAGR PROJECTIONS (2023-2028)
    • FIGURE 7 CELL ANALYSIS MARKET: ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • 2.4 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 INSIGHTS FROM PRIMARIES
    • FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 CELL ANALYSIS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 CELL ANALYSIS MARKET, BY PROCESS, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 CELL ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 CELL ANALYSIS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 CELL ANALYSIS MARKET OVERVIEW
    • FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CELL ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE (2022)
    • FIGURE 16 REAGENTS & CONSUMABLES SEGMENT HELD LARGEST MARKET SHARE IN 2022
  • 4.3 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 FLOW CYTOMETRY SEGMENT TO DOMINATE NORTH AMERICAN MARKET IN 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 CELL ANALYSIS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing preference for cell-based assays in drug discovery
      • 5.2.1.2 Increasing funding for cell-based research
    • TABLE 2 NIH FUNDING FOR CELL-BASED RESEARCH, 2019-2021 (USD MILLION)
      • 5.2.1.3 Rising number of drug discovery activities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of instruments and restrictions on reagent use
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth potential of single-cell sequencing
      • 5.2.3.2 Application scope of novel cell-based assays in cancer research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 19 CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 20 CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
  • 5.6 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS)
    • 5.6.1 STRINGENT FDA REQUIREMENTS
    • 5.6.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
    • 5.6.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
    • 5.6.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
    • 5.6.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
    • 5.6.6 US REIMBURSEMENT SCENARIO
  • 5.7 TECHNOLOGY ANALYSIS
    • FIGURE 21 TECHNOLOGY ANALYSIS: CELL ANALYSIS MARKET
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 22 CELL ANALYSIS MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • 5.9.2 CELL ANALYSIS MARKET: BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA OF CELL ANALYSIS PRODUCTS
  • 5.10 KEY CONFERENCES AND EVENTS, 2023-2024
    • TABLE 4 CELL ANALYSIS CONFERENCES (2023-2024)
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES
    • TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES (TOP 5 KEY PLAYERS)**
    • 5.11.2 AVERAGE SELLING PRICE TREND

6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 REAGENTS & CONSUMABLES
    • 6.2.1 DEVELOPMENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST GROWTH
    • TABLE 7 REAGENTS & CONSUMABLES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 8 NORTH AMERICA: CELL ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 9 EUROPE: CELL ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 10 ASIA PACIFIC: CELL ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY TO DRIVE MARKET
    • TABLE 11 INSTRUMENTS: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 12 NORTH AMERICA: CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 13 EUROPE: CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 14 ASIA PACIFIC: CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 USE OF ACCESSORIES TO CUSTOMIZE FLOW CYTOMETRY INSTRUMENTS TO BOOST SEGMENT GROWTH
    • TABLE 15 ACCESSORIES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 EUROPE: CELL ANALYSIS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5 SOFTWARE
    • 6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE DATA INTERPRETATION SOFTWARE TO DRIVE SEGMENT
    • TABLE 19 SOFTWARE: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 NORTH AMERICA: CELL ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 EUROPE: CELL ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.6 SERVICES
    • 6.6.1 WORKFLOW CONTINUITY AND HIGH-PERFORMANCE ATTRIBUTES TO BOOST DEMAND FOR REMOTE SERVICES
    • TABLE 23 SERVICES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 24 NORTH AMERICA: CELL ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 EUROPE: CELL ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 CELL ANALYSIS MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 27 CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 7.2 FLOW CYTOMETRY
    • 7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS TO DRIVE SEGMENT
    • TABLE 28 FLOW CYTOMETRY: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 NORTH AMERICA: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 EUROPE: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 PCR
    • 7.3.1 EFFECTIVE MEASUREMENT AND RARE SEQUENCE MONITORING BENEFITS TO DRIVE DIGITAL PCR DEMAND
    • TABLE 32 PCR: CELL ANALYSIS MARKET FOR PCR, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 CELL MICROARRAYS
    • 7.4.1 HIGH EXPERIMENTAL THROUGHPUT OF CELL MICROARRAYS OVER TRADITIONAL METHODS TO DRIVE SEGMENT
    • TABLE 36 CELL MICROARRAYS: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 EUROPE: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 MICROSCOPY
    • 7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN CELL BIOLOGY TO DRIVE SEGMENT
    • TABLE 40 MICROSCOPY: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 SPECTROPHOTOMETRY
    • 7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH
    • TABLE 44 SPECTROPHOTOMETRY: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 HIGH-CONTENT SCREENING
    • 7.7.1 HIGH DEMAND FOR HCS IN DRUG DISCOVERY TO SUPPORT SEGMENT GROWTH
    • TABLE 48 HIGH-CONTENT SCREENING: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.8 OTHER TECHNIQUES
    • TABLE 52 OTHER TECHNIQUES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 EUROPE: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)

8 CELL ANALYSIS MARKET, BY PROCESS

  • 8.1 INTRODUCTION
    • TABLE 56 CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
  • 8.2 CELL IDENTIFICATION
    • 8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL SEGMENT GROWTH
    • TABLE 57 CELL IDENTIFICATION: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 58 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 EUROPE: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CELL VIABILITY
    • 8.3.1 USE OF CELL VIABILITY PROCESS TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS
    • TABLE 61 CELL VIABILITY: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION
    • 8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET
    • TABLE 65 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 66 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 CELL PROLIFERATION
    • 8.5.1 MEASUREMENT OF CELL PROLIFERATION BASED ON AVERAGE DNA CONTENT TO DRIVE SEGMENT
    • TABLE 69 CELL PROLIFERATION: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 70 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 CELL COUNTING AND QUALITY CONTROL
    • 8.6.1 USE OF FLOW CYTOMETRY IN CELL COUNTING TO ENABLE EASY CELL DIFFERENTIATION VIA SCATTERING OR STAINING
    • TABLE 73 CELL COUNTING AND QUALITY CONTROL: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 74 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 EUROPE: CELL ANALYSIS MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL COUNTING AND QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.7 CELL INTERACTION
    • 8.7.1 ADVANCEMENT IN CELL-CELL INTERACTIONS/COMMUNICATIONS TO BOOST MARKET GROWTH
    • TABLE 77 CELL INTERACTION: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.8 CELL STRUCTURE STUDY
    • 8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH
    • TABLE 81 CELL STRUCTURE STUDY: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.9 TARGET IDENTIFICATION AND VALIDATION
    • 8.9.1 ADOPTION OF HIGH-CONTENT SCREENING IN TARGET IDENTIFICATION TO DRIVE MARKET
    • TABLE 85 TARGET IDENTIFICATION AND VALIDATION: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.10 SINGLE-CELL ANALYSIS
    • 8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH
    • TABLE 89 SINGLE-CELL ANALYSIS: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 90 NORTH AMERICA: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 EUROPE: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)

9 CELL ANALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 93 CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE SEGMENT
    • TABLE 94 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: CELL ANALYSIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 EUROPE: CELL ANALYSIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 HOSPITALS AND CLINICAL TESTING LABORATORIES
    • 9.3.1 ADOPTION OF ADVANCED TECHNOLOGIES TO SUPPORT MARKET GROWTH
    • TABLE 98 HOSPITALS AND CLINICAL TESTING LABORATORIES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: CELL ANALYSIS MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 EUROPE: CELL ANALYSIS MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC AND RESEARCH INSTITUTES
    • 9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
    • TABLE 102 ACADEMIC AND RESEARCH INSTITUTES: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 103 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 EUROPE: CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 106 OTHER END USERS: CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 CELL ANALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 110 CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 111 NORTH AMERICA: CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 114 NORTH AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising prevalence of cancer to drive cell analysis demand in US
    • TABLE 116 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 117 US: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 118 US: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 119 US: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market
    • TABLE 120 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 121 CANADA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 122 CANADA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 123 CANADA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 124 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 125 EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 127 EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Strong R&D infrastructure, training, and awareness programs to drive market in Germany
    • TABLE 129 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 GERMANY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 131 GERMANY: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 132 GERMANY: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Presence of large biotechnology industry to boost market growth
    • TABLE 133 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 134 FRANCE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 135 FRANCE: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 136 FRANCE: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market
    • TABLE 137 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 UK: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 139 UK: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 140 UK: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing research activities and conferences to support market growth
    • TABLE 141 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 ITALY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 143 ITALY: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 144 ITALY: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Strong focus on cancer diagnosis to boost flow cytometry product usage in Spain
    • TABLE 145 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 146 SPAIN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 147 SPAIN: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 148 SPAIN: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 149 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 25 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 153 ASIA PACIFIC: CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth
    • TABLE 158 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 159 JAPAN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 160 JAPAN: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 161 JAPAN: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Strategic partnerships in cell therapy sector to support market growth
    • TABLE 162 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 163 CHINA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 164 CHINA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 165 CHINA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives to drive market in India
    • TABLE 166 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 167 INDIA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 168 INDIA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 169 INDIA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 170 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 171 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 172 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
    • TABLE 174 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 175 LATIN AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 176 LATIN AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 177 LATIN AMERICA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GROWING RESEARCH ACTIVITIES TO FUEL DEMAND FOR CELL ANALYSIS PRODUCTS
    • TABLE 178 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PROCESS, 2021-2028 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 26 CELL ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 27 CELL ANALYSIS MARKET SHARE ANALYSIS (2022)
  • 11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS)
    • FIGURE 28 REVENUE ANALYSIS FOR KEY COMPANIES, 2021-2022
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 29 CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 11.6 COMPETITIVE LEADERSHIP MAPPING FOR EMERGING COMPANIES/SMES/START-UPS (2022)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 30 CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2022
  • 11.7 COMPETITIVE SCENARIO AND TRENDS
    • 11.7.1 PRODUCT LAUNCHES
    • TABLE 182 CELL ANALYSIS MARKET: PRODUCT LAUNCHES
    • 11.7.2 DEALS
    • TABLE 183 CELL ANALYSIS MARKET: DEALS

12 COMPANY PROFILES

  • 12.1 KEY COMPANIES
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • TABLE 184 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
    • FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
    • TABLE 185 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
    • TABLE 186 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES
    • TABLE 187 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 12.1.2 DANAHER
    • TABLE 188 DANAHER: COMPANY OVERVIEW
    • FIGURE 32 DANAHER: COMPANY SNAPSHOT (2022)
    • TABLE 189 DANAHER: PRODUCT OFFERINGS
    • TABLE 190 DANAHER: DEALS
    • TABLE 191 DANAHER: OTHER DEVELOPMENTS
    • 12.1.3 BECTON, DICKINSON AND COMPANY (BD)
    • TABLE 192 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
    • FIGURE 33 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT (2022)
    • TABLE 193 BECTON, DICKINSON AND COMPANY (BD): PRODUCT OFFERINGS
    • TABLE 194 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES
    • 12.1.4 GENERAL ELECTRIC
    • TABLE 195 GENERAL ELECTRIC: COMPANY OVERVIEW
    • FIGURE 34 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
    • TABLE 196 GENERAL ELECTRIC: PRODUCT OFFERINGS
    • 12.1.5 MERCK KGAA
    • TABLE 197 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • TABLE 198 MERCK KGAA: PRODUCT OFFERINGS
    • 12.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 199 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 200 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
    • TABLE 201 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
    • 12.1.7 BIO-RAD LABORATORIES, INC.
    • TABLE 202 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 37 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 203 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
    • TABLE 204 BIO-RAD LABORATORIES, INC.: DEALS
    • 12.1.8 STANDARD BIOTOOLS
    • TABLE 205 STANDARD BIOTOOLS: COMPANY OVERVIEW
    • FIGURE 38 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
    • TABLE 206 STANDARD BIOTOOLS: PRODUCT OFFERINGS
    • 12.1.9 MILTENYI BIOTEC
    • TABLE 207 MILTENYI BIOTEC: COMPANY OVERVIEW
    • TABLE 208 MILTENYI BIOTEC: PRODUCT OFFERINGS
    • TABLE 209 MILTENYI BIOTEC: PRODUCT LAUNCHES
    • 12.1.10 OLYMPUS CORPORATION
    • TABLE 210 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 211 OLYMPUS CORPORATION: PRODUCT OFFERINGS
    • 12.1.11 BIOSTATUS LIMITED
    • TABLE 212 BIOSTATUS LIMITED: COMPANY OVERVIEW
    • TABLE 213 BIOSTATUS LIMITED: PRODUCT OFFERINGS
    • 12.1.12 NANOCELLECT BIOMEDICAL
    • TABLE 214 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW
    • TABLE 215 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS
    • TABLE 216 NANOCELLECT BIOMEDICAL: DEALS
    • TABLE 217 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCHES
    • 12.1.13 CELL BIOLABS, INC.
    • TABLE 218 CELL BIOLABS, INC.: COMPANY OVERVIEW
    • TABLE 219 CELL BIOLABS, INC.: PRODUCT OFFERINGS
    • 12.1.14 CREATIVE BIOARRAY
    • TABLE 220 CREATIVE BIOARRAY: COMPANY OVERVIEW
    • TABLE 221 CREATIVE BIOARRAY: SERVICE OFFERINGS
    • 12.1.15 MEIJI TECHNO
    • TABLE 222 MEIJI TECHNO: COMPANY OVERVIEW
    • TABLE 223 MEIJI TECHNO: PRODUCT OFFERINGS
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 PROMEGA CORPORATION
    • TABLE 224 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 12.2.2 PERKINELMER U.S. LLC
    • TABLE 225 PERKINELMER: COMPANY OVERVIEW
    • 12.2.3 TECAN TRADING AG
    • TABLE 226 TECAN TRADING AG: COMPANY OVERVIEW
    • 12.2.4 CARL ZEISS AG
    • TABLE 227 CARL ZEISS AG: COMPANY OVERVIEW
    • 12.2.5 SYSMEX
    • TABLE 228 SYSMEX: COMPANY OVERVIEW
    • 12.2.6 CELLINK
    • TABLE 229 CELLINK: COMPANY OVERVIEW
    • 12.2.7 QIAGEN
    • TABLE 230 QIAGEN: COMPANY OVERVIEW
    • 12.2.8 ILLUMINA, INC.
    • TABLE 231 ILLUMINA, INC.: COMPANY OVERVIEW
    • 12.2.9 CORNING INCORPORATED
    • TABLE 232 CORNING INCORPORATED: COMPANY OVERVIEW
    • 12.2.10 10X GENOMICS
    • TABLE 233 10X GENOMICS: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS